EarlBoyle

    • EarlBoyleEarlBoyle
      ·11-07
      $Lyft, Inc.(LYFT)$ Solid gains on LYFT! Slow but steady moves as travel demand recovers and cost cuts kick in. Keeping my position for now, waiting for earnings to deliver some surprises.
      671Comment
      Report
    • EarlBoyleEarlBoyle
      ·09-12
      $Bilibili Inc.(BILI)$ 's fundamentals are solid with high user loyalty and a large youth base. While it can't compare to giants like NVIDIA, its profitability keeps improving—minor fluctuations don’t shake the long-term outlook.
      1.07KComment
      Report
    • EarlBoyleEarlBoyle
      ·08-13
      $Oklo Inc.(OKLO)$ has had several recent highlights: fresh funding unlocked, regulatory progress, and fuel deals secured. Keep an eye on Auroro kickoff in Q3—COLA submission and partnership execution will be catalysts. Cash management matters.
      1.31KComment
      Report
    • EarlBoyleEarlBoyle
      ·07-14
      $NVIDIA(NVDA)$ In the past few days, Nvidia’s QX CPO switch launched early for pre-orders, with pricing and device orders both exceeding expectations. The attention from senior officials in both China and the U.S. has also been beyond expectations. Technology is the pillar of the future—deeply committed to Nvidia!
      1.67KComment
      Report
    • EarlBoyleEarlBoyle
      ·06-20
      $MAOYAN ENT(01896)$ As China’s film industry bounces back, I’ve placed my bet on Maoyan Entertainment and it paid off. With over 60% market share in online ticketing and a leading role in major film distribution, Maoyan is clearly ahead of the curve. Their deep insights into consumer trends and content distribution make them a key driver in the recovery of the cinema market. This profit isn’t just numbers , it’s a reward for conviction and recognizing the right trend early. Still bullish and holding strong!
      1.44KComment
      Report
    • EarlBoyleEarlBoyle
      ·05-23
      $HUTCHMED(00013)$ In my trading system, one rule stands out: you gotta know what kind of money you’re making! Is it from company growth? Value discovery? Or just pure speculation? Honestly, with the pharma rally going strong, many are disappointed in Hutchison. But for me, it’s a solid stock for day trading. Each gain might be small, but over time, it adds up,I’ve made tens of thousands steadily.
      1.56KComment
      Report
    • EarlBoyleEarlBoyle
      ·04-25
      $GraniteShares 2x Long COIN Daily ETF(CONL)$ With rate cuts on the horizon and the tariff noise behind us, the setup for crypto is looking solid. CONL is built for this kind of momentum. When the trend's your friend, you ride it hard. I’m in because the logic makes sense, and this one’s got juicy upside. You see it, you get it, you profit. Simple as that.
      1.87KComment
      Report
    • EarlBoyleEarlBoyle
      ·03-31
      $DONGFENG GROUP(00489)$ In the increasingly competitive new energy vehicle industry, mergers and acquisitions have become an important strategy to tackle industry overcrowding. At the 2024 earnings communication meeting of Dongfeng Motors, a subsidiary of Dongfeng Group, the management announced that the integration with Changan Group is underway, with plans to restructure Changan's automotive division. I believe if the strategic merger with Changan is successful, Dongfeng Motors' market value could reach HKD 80 billion, making it comparable in value to Changan Group.
      1.80KComment
      Report
    • EarlBoyleEarlBoyle
      ·02-28
      $ProShares UltraPro Short Russell2000(SRTY)$ These hedging-type stocks are really interesting! After some observation and research, I see how they perform consistently well during market fluctuations, effectively mitigating risks while delivering returns. Looking forward to diving deeper and uncovering more potential!
      2.17KComment
      Report
    • EarlBoyleEarlBoyle
      ·01-20
      $Marvell Technology(MRVL)$ ’s recent performance has been steadily rising, a perfect example of stable growth. Today’s gains were impressive once again. Thanks to CBA!
      2.41KComment
      Report
     
     
     
     

    Most Discussed